On the assessment of contamination and analysis of control samples in toxicokinetics studies
Open Access
- 1 September 2024
- journal article
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 11 (4) , 351-363
Abstract
Relevance. The evaluation of control samples contamination is a necessary element for confirming the correctness of toxicokinetic studies (TK), concomitant with the study of toxicity of drugs and products. At the same time, insufficient elaboration of existing regulatory documents necessitates discussion of practical aspects and improvement of the regulatory framework. Purpose. The work is devoted to the consideration of experimental experience of control samples contamination in TK studies. Materials and methods. As experimental examples, two studies of TK drugs performed using rabbits with oral administration of study drugs for 28 (Study 1) or 90 (Study 2) days were considered. Results. Study 1 revealed a contamination level of 17–25 % (on the first and last days of study drug administration, respectively). Contamination of bioassays can occur in vivo (contamination of animals) and ex vivo (at the stage of bioassay sampling, at the pre-analytical stage and analytical stage). The nature of the analyte detection in the samples made it possible to exclude contamination in vivo, and the results of an internal investigation suggested that it occurred at the stage of biosample selection. In Study 2, a number of preventive measures were implemented and a slight level of contamination was obtained (0.83 %), which did not affect the completeness and correctness of results interpretation. Conclusion. Based on experimental experience, recommendations for minimizing and preventing contamination of control samples during the biological part, pre-analytical and analytical stages of studies were formulated. Presumably, in the presence of a random nature of contamination indicating its ex vivo origin, the level of contamination not exceeding 25 % can be considered insignificant, i.e. not leading to further deviation and cancellation of the results of the entire studyKeywords
This publication has 14 references indexed in Scilit:
- Identification of a frit-related sample carryover in newborn screening by tandem mass spectrometryJournal of Mass Spectrometry and Advances in the Clinical Lab, 2023
- Ten-day and four-week toxicity and toxicokinetics studies of alpha-glycosyl isoquercitrin in juvenile Göttingen minipigsToxicology Research and Application, 2019
- A comparison of toxicity and toxicokinetics in rats and dogs following twenty-eight-day, repeat-dose oral administration of nifurtimoxToxicology Research, 2017
- Evaluation and Elimination of Carryover and/or Contamination in LC‐MS Bioanalysis2013
- Beyond pass/fail: A procedure for evaluating the effect of carryover in bioanalytical LC/MS/MS methodsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Lanthanum pharmacokinetics: Are rat data misleading?Kidney International, 2005
- The need for contamination control in studies on lanthanum biodisposition.Kidney International, 2005
- The presence of drug in control samples during toxicokinetic investigations—A Novartis perspectiveRegulatory Toxicology and Pharmacology, 2005
- Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administrationKidney International, 2005
- Differences Between Pharmacokinetics and ToxicokineticsToxicologic Pathology, 1995